ATC Group: D05A Antipsoriatics for topical use

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D05A in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D05 Antipsoriatics
3 D05A Antipsoriatics for topical use

Group D05A contents

Code Title
D05AA Tars
D05AC Antracen derivatives
D05AD Psoralens for topical use
D05AX Other antipsoriatics for topical use

Active ingredients in D05A

Active Ingredient

Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing.

Calcitriol is the most active known form of vitamin D3 in stimulating intestinal calcium transport. In physiological amounts it augments the intestinal absorption of calcium and phosphate and plays a significant part in the regulation of bone mineralisation.

Coal tar is an antipruritic and keratoplastic. It is used in eczema, psoriasis and other skin conditions. Tar acids have also been shown to have disinfectant properties. Coal tar may be used alone, or as part of a more extensive treatment regimen.

Dithranol has been used in the treatment of sub-acute and chronic psoriasis for over 70 years and, during that time it has become established as a safe and effective form of therapy. Its precise mode of action is still to be confirmed, although it has been shown to inhibit DNA replication, cellular respiration and key cellular enzymes eg glucose-6-phosphate dehydrogenase.

Methoxsalen, upon photoactivation, conjugates and forms covalent bonds with DNA which leads to the formation of both monofunctional (addition to a single strand of DNA) and bifunctional adducts (crosslinking of psoralen to both strands of DNA). Reactions with proteins have also been described. The formation of photoadducts results in inhibition of DNA synthesis, cell division and epidermal turnover.

Roflumilast is a PDE4 inhibitor, a non-steroid, anti-inflammatory active substance designed to target both the systemic and pulmonary inflammation associated with COPD.

Tacalcitol is a vitamin D3 derivative, which inhibits keratinocyte hyper-proliferation and induces differentiation of these cells. The normalisation of these mechanisms is the basis for the efficacy in the treatment of psoriasis.

Tapinarof is an aryl hydrocarbon receptor (AhR) agonist. The specific mechanisms by which tapinarof cream exerts its therapeutic action in psoriasis patients are unknown.

Tazarotene, a member of the acetylenic class of retinoids, is a prodrug which is converted to its active free form, tazarotenic acid, by de-esterification in the skin area. Tazarotenic acid is the only known metabolite of tazarotene to have retinoid activity.

Related product monographs

Document Type Information Source  
 COAL TAR (EXOREX) LOTION Cutaneous emulsion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 CURATODERM Ointment MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DAIVOBET Gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DAIVONEX Ointment MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 DITHROCREAM Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DOVOBET Gel MPI, EU: SmPC Health Products Regulatory Authority (IE)
 Dovonex Ointment MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ENSTILAR Foam MPI, US: SPL/PLR FDA, National Drug Code (US)
 PSORIDERM Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 SILKIS Ointment MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TAZORAC Cream MPI, US: SPL/PLR FDA, National Drug Code (US)
 TAZORAC Gel MPI, US: SPL/PLR FDA, National Drug Code (US)
 VTAMA Cream MPI, US: SPL/PLR FDA, National Drug Code (US)
 ZORAC Gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)